Tilman M. Hackeng

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Journal: Thrombosis and haemostasis

Published: June 30, 2026

Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A.

Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A.

Journal: Research and practice in thrombosis and haemostasis

Published: February 27, 2026

Tissue Factor/Factor XIa Dual-activated Thrombin Generation is Able to Reliably Measure Thrombin Generation at All Hemophilia A Disease Severities.

Tissue Factor/Factor XIa Dual-activated Thrombin Generation is Able to Reliably Measure Thrombin Generation at All Hemophilia A Disease Severities.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: December 29, 2025

Recurrent venous thromboembolism: association with thrombin generation and d-dimer.

Recurrent venous thromboembolism: association with thrombin generation and d-dimer.

Journal: Research and practice in thrombosis and haemostasis

Published: December 07, 2025

Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display.

Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display.

Journal: ACS chemical biology

Published: October 29, 2025

Calcium binding by γ-carboxyglutamic acid: it takes two to tether.

Calcium binding by γ-carboxyglutamic acid: it takes two to tether.

Journal: Research and practice in thrombosis and haemostasis

Published: May 06, 2025

Risk of First Venous Thrombosis by Comparing Different Thrombin Generation Assay Conditions: Results from the MEGA Case-control Study.

Risk of First Venous Thrombosis by Comparing Different Thrombin Generation Assay Conditions: Results from the MEGA Case-control Study.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: December 06, 2024

Citrullination of tissue factor pathway inhibitor alpha by peptidylarginine deiminase 4 impairs its natural anticoagulant activity toward factors Xa and VIIa/tissue factor and reduces binding to its cofactor protein S.

Citrullination of tissue factor pathway inhibitor alpha by peptidylarginine deiminase 4 impairs its natural anticoagulant activity toward factors Xa and VIIa/tissue factor and reduces binding to its cofactor protein S.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 30, 2024

Why Current Detection of Vascular Calcification Falls Short and How to Improve on It.

Why Current Detection of Vascular Calcification Falls Short and How to Improve on It.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: July 04, 2024

Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?

Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?

Journal: The journal of applied laboratory medicine

Published: March 12, 2024

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 30, 2023

CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization.

CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization.

Journal: Frontiers in immunology

Published: October 24, 2023

Showing 1-12 of 119

Last Updated: 09/26/2026